HIGH-VOLUME · HOSP-MID

atorvastatin Side Effects

atorvastatin (also sold as Lipitor) is HIGH-VOLUME in this FAERS book #23 of 524 by FAERS report count. Signature opener: HOSP-MID - 28.5% mention hospitalization (68,513 reports).

Data updated 2026-05-15

240,204
FAERS reports

FAERS voluntary reports, 2000 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

atorvastatin: 28.5% mention hospitalization (68,513 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #23 of 524 by FAERS report count.

High-report extract for atorvastatin (Lipitor): 240,204 FAERS rows (2000-2025). Top named reactions: FATIGUE, NAUSEA, TYPE 2 DIABETES MELLITUS. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2000–2025). Stamps MEGA-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.

FATIGUE leads 13,812 of 240,204 reports

FATIGUE
13,812
NAUSEA
12,425
TYPE 2 DIABETES MELLITUS
11,244
DIARRHOEA
11,037
DYSPNOEA
11,029
PAIN
10,041
MYALGIA
9,801
DIZZINESS
9,713
HEADACHE
9,650
ASTHENIA
8,837
ARTHRALGIA
8,510
PAIN IN EXTREMITY
8,172
FALL
7,836
DEATH
7,428
MALAISE
6,892
WEIGHT DECREASED
6,768
MYOCARDIAL INFARCTION
6,663
VOMITING
6,318

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 121,275 (54%)
Male 102,566 (45%)
Unknown 2,298

Age peak 45-64 (56,931 reports)

0-17 569 (0%)
18-44 7,262 (5%)
45-64 56,931 (39%)
65-74 44,581 (30%)
75+ 38,431 (26%)

FAERS filings rising toward 2025

2000 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (18,385 reports, 7.7%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 7,408
MYOCARDIAL INFARCTION 1,271
PNEUMONIA 1,099
RENAL FAILURE 1,015
DYSPNOEA 1,012
SEPSIS 792
DIARRHOEA 788
ASTHENIA 763
CARDIAC ARREST 763
FALL 762
NAUSEA 722
FATIGUE 717
RESPIRATORY FAILURE 672
CARDIAC FAILURE CONGESTIVE 660
CEREBROVASCULAR ACCIDENT 597
ACUTE KIDNEY INJURY 586
VOMITING 565
HYPOTENSION 561
PAIN 555
CARDIO-RESPIRATORY ARREST 553

Reactions in Hospitalization Reports

Hospitalization mid-share (68,513, 28.5%). Co-reported reactions:

Reaction Reports
DYSPNOEA 5,530
PNEUMONIA 4,694
FALL 4,618
NAUSEA 4,471
MYOCARDIAL INFARCTION 4,368
FATIGUE 4,074
DIARRHOEA 3,997
ASTHENIA 3,897
PAIN 3,470
CEREBROVASCULAR ACCIDENT 3,390
DIZZINESS 3,265
VOMITING 3,128
CHEST PAIN 2,995
HEADACHE 2,987
PYREXIA 2,875
WEIGHT DECREASED 2,865
MALAISE 2,785
ANAEMIA 2,588
CARDIAC FAILURE CONGESTIVE 2,585
HYPOTENSION 2,430
How to read atorvastatin FAERS figures (MEGA-CASE · DEATH-HEAVY · HOSP-MID)

FAERS holds 240,204 voluntary reports linked to atorvastatin (Lipitor), 2000-2025. Death is listed on 18,385 (7.7%). Hospitalization appears on 68,513 (28.5%). Top co-reported indication: Product Used For Unknown Indication.

MEGA-CASE books overweight common drugs and loud reporting cultures; HOSP-MID is the page opener, not a per-patient risk.

Read with atorvastatin

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.